Targeting survivin (BIRC5) with YM155 for the treatment of head and neck squamous cell carcinoma

被引：0
|
作者：
Kumar, Bhavna [1 ]
Yadav, Arti [1 ]
Teknos, Theodoros N. [1 ]
Kumar, Pawan [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5604
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
    Liu, Shuo
    Qin, Zhen
    Mao, Yaqing
    Zhang, Wenbo
    Wang, Yujia
    Jia, Lingfei
    Peng, Xin
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [42] Hypoxia selectively confers resistance to the survivin-targeting compound YM155 in acute myeloid leukemia and Ewings sarcoma cell lines
    Montoya, Justin
    Finch, Kieran
    Simper, Jan
    Arceci, Robert J.
    Aleem, Eiman A.
    CANCER RESEARCH, 2016, 76
  • [43] Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck
    Schmitz, Sandra
    Machiels, Jean-Pascal
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (07)
  • [44] Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck
    Sandra Schmitz
    Jean-Pascal Machiels
    Current Treatment Options in Oncology, 2016, 17
  • [45] Targeting Epigenetic Dysregulations in Head and Neck Squamous Cell Carcinoma
    Li, Y.
    Lu, C.
    JOURNAL OF DENTAL RESEARCH, 2025, 104 (03) : 225 - 234
  • [46] Targeting cell survival pathways in head and neck squamous cell carcinoma
    Johnson, Daniel E.
    Li, Changyou
    Thomas, Sufi M.
    Grandis, Jennifer R.
    Zang, Yan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S23 - S23
  • [47] Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma
    Li, Kong-Liang
    Wang, Yu-Fan
    Qin, Jia-Ruo
    Wang, Feng
    Yang, Yong-Tao
    Zheng, Li-Wu
    Li, Ming-Hua
    Kong, Jie
    Zhang, Wei
    Yang, Hong-Yu
    TUMOR BIOLOGY, 2017, 39 (06)
  • [48] Targeting inhibitors of apoptosis in combination with radiation for the treatment of head and neck squamous cell carcinoma
    Yang, Linlin
    Kumar, Bhavna
    Li, Tianyun
    Teknos, Thenodoros N.
    Chakravarti, Arnab
    Williams, Terence M.
    CANCER RESEARCH, 2017, 77
  • [49] Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker
    Mulay, Kaustubh
    Puthyapurayil, Fairooz M.
    Mohammad, Javed Ali
    Ali, Mohammad Hasnat
    Honavar, Santosh G.
    Reddy, Vijay Anand P.
    HISTOPATHOLOGY, 2013, 62 (06) : 840 - 846
  • [50] Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
    Michaelis, Martin
    Voges, Yvonne
    Rothweiler, Florian
    Weipert, Fabian
    Zia-Ahmad, Amara
    Cinatl, Jaroslav
    von Deimling, Andreas
    Westermann, Frank
    Roedel, Franz
    Wass, Mark N.
    Cinatl, Jindrich, Jr.
    CANCERS, 2020, 12 (03)
12345